A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products (NCT05476926)
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY)
🩺 Plain-English Summary (8th-Grade Level)
The VOYAGER study is a primary data collection, non-interventional, prospective, multinational, multicenter study. It is designed to collect real-world, long-term data to explore long-term effectiveness, safety, clinical insights, treatment patterns, and factors driving the treatment decisions among patients being treated with specified Roche ophthalmology products in approved retinal indications (Faricimab for neovascular age-related macular degeneration \[nAMD\], diabetic macular edema \[DME\], and retinal vein occlusion; Port Delivery System with Ranibizumab for nAMD) in routine clinical practice. This study will not provide or make recommendations on use of any products including Roche products; treatment decisions will be determined by the treating physician and must be made independently to the decision to participate in this study. Participation in this study will not change or influence a patient's standard of care in any way.
Who can join: Review the eligibility criteria below.
Location: Retinal Research Institute, LLC — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (299 Sites)
Showing the first 25 of 299 sites.
- Retinal Research Institute, LLC — Phoenix, Arizona
- California Eye Specialists Medical group Inc. — Pasadena, California
- Retinal Consultants Medical Group — Sacramento, California
- Advanced Research — Coral Springs, Florida
- Retina Specialty Institute — Pensacola, Florida
- University Retina and Macula Associates, PC — Lemont, Illinois
- Springfield Clinic, Llp — Springfield, Illinois
- Retina Associates of Kentucky — Lexington, Kentucky
- Cumberland Valley Retina Consultants PC — Hagerstown, Maryland
- Associated Retinal Consultants PC — Royal Oak, Michigan
- Erie Retinal Surgery — Erie, Pennsylvania
- Tennessee Retina PC — Nashville, Tennessee
- Brown Retina Institute — San Antonio, Texas
- Retina Center of Texas — Southlake, Texas
- University of Utah, John Moran Eye Center — Salt Lake City, Utah
- Piedmont Eye Center — Lynchburg, Virginia
- Wagner Macula and Retina Center — Norfolk, Virginia
- Spokane Eye Clinical Research — Spokane, Washington
- Salud Ocular — Ciudad Autonoma de Buenos Aires, Buenos Aires
- Instituto Oftalmologico de Buenos Aires S.A. — Buenos Aires,
- Centro Oftalmologico Dr. Charles S.A. — Ciudad Autonoma Buenos Aires,
- Centro Privado de Ojos Romagosa S.A — Córdoba,
- CEO Centro de Especialidades Oftalmologicas Tucuman — San Miguel de Tucumán,
- Retina and Macula Specialists — Hurstville, New South Wales
- Sydney West Retina — Westmead, New South Wales
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Neovascular Age-related Macular Degeneration
- A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) — Arcadia, California
- A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration — Phoenix, Arizona
- Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) — Beverly Hills, California
- Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration — Gilbert, Arizona
- Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — Glendale, California
- Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA] — Phoenix, Arizona
Explore by condition: All Neovascular Age-related Macular Degeneration clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.